Assignee
CureVac SE
DE·62 granted patents·56 pending applications·182 citations·filing 2016–2025
Top patents by PatentIndex Score
118 records- 0198US11965000B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·7 cites·30 claims
- 0298US11739125B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2021·Granted Aug 29, 2023·10 cites·15 claims
- 0397US11761009B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2022·Granted Sep 19, 2023·5 cites·60 claims
- 0497US11596686B2Coronavirus vaccineCureVac SE·Filed 2022·Granted Mar 7, 2023·16 cites·30 claims
- 0597US11576966B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Feb 14, 2023·16 cites·27 claims
- 0696US12318486B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Jun 3, 2025·3 cites·16 claims
- 0796US12138348B2Dry powder composition comprising long-chain RNACureVac SE·Filed 2022·Granted Nov 12, 2024·3 cites·20 claims
- 0896US11786590B2Rotavirus vaccinesCureVac SE·Filed 2022·Granted Oct 17, 2023·5 cites·16 claims
- 0995US12442005B2Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2023·Granted Oct 14, 2025·1 cites·41 claims
- 1095US11964012B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·2 cites·29 claims
- 1195US11596699B2RNA encoding an antibodyCureVac SE·Filed 2017·Granted Mar 7, 2023·11 cites·19 claims
- 1295US11559570B2Prime-boost regimens involving administration of at least one mRNA constructCureVac SE·Filed 2016·Granted Jan 24, 2023·8 cites·22 claims
- 1394US12318444B2Rotavirus vaccinesCureVac SE·Filed 2023·Granted Jun 3, 2025·1 cites·20 claims
- 1494US12168050B2Compositions comprising a norovirus nucleic acid and methods of use thereofCureVac SE·Filed 2021·Granted Dec 17, 2024·4 cites·28 claims
- 1594US11602557B2Bunyavirales vaccineCureVac SE·Filed 2018·Granted Mar 14, 2023·11 cites·20 claims
- 1693US11690910B2Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigenCureVac SE·Filed 2019·Granted Jul 4, 2023·6 cites·20 claims
- 1792US12240873B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Mar 4, 2025·0 cites·46 claims
- 1892US11918643B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2021·Granted Mar 5, 2024·6 cites·27 claims
- 1992US11524066B2Henipavirus vaccineCureVac SE·Filed 2017·Granted Dec 13, 2022·8 cites·19 claims
- 2092US2025129128A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2024·Application pending·0 cites
- 2192US2025352636A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigenCureVac SE·Filed 2024·Application pending·0 cites
- 2291US12161711B2Lassa virus vaccineCureVac SE·Filed 2022·Granted Dec 10, 2024·1 cites·14 claims
- 2391US12139513B2Respiratory syncytial virus (RSV) vaccineCureVac SE·Filed 2024·Granted Nov 12, 2024·0 cites·44 claims
- 2491US12097253B2RSV RNA molecules and compositions for vaccinationCureVac SE·Filed 2024·Granted Sep 24, 2024·1 cites·45 claims
- 2591US11872280B2RNA vaccine against SARS-CoV-2 variantsCureVac SE·Filed 2022·Granted Jan 16, 2024·5 cites·24 claims
- 2691US11692002B2RNA sequence adaptationCureVac SE·Filed 2018·Granted Jul 4, 2023·7 cites·22 claims
- 2791US11525158B2Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNACureVac SE·Filed 2018·Granted Dec 13, 2022·8 cites·19 claims
- 2891US2026028627A1Artificial nucleic acid molecules for improved protein or peptide expressionCureVac SE·Filed 2025·Application pending·0 cites
- 2991US2025345411A1Vaccination in newborns and infantsCureVac SE·Filed 2025·Application pending·0 cites
- 3091US2026091107A1Coronavirus vaccineCureVac SE·Filed 2025·Application pending·0 cites
- 3190US12036277B2Vaccination with mRNA-coded antigensCureVac SE·Filed 2024·Granted Jul 16, 2024·0 cites·24 claims
- 3290US11697816B2Artificial nucleic acid moleculesCureVac SE·Filed 2016·Granted Jul 11, 2023·5 cites·22 claims
- 3390US11608513B2Method for adding cap structures to RNA using immobilized enzymesCureVac SE·Filed 2016·Granted Mar 21, 2023·7 cites·15 claims
- 3489US11739335B2Nucleic acids encoding CRISPR-associated proteins and uses thereofCureVac SE·Filed 2018·Granted Aug 29, 2023·7 cites·18 claims
- 3589US2024390478A1Vaccination in elderly patientsCureVac SE·Filed 2024·Application pending·0 cites
- 3688US12390520B2Vaccination in newborns and infantsCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·47 claims
- 3788US12194089B2Coronavirus vaccineCureVac SE·Filed 2021·Granted Jan 14, 2025·1 cites·52 claims
- 3888US2023382954A1Respiratory syncytial virus (rsv) vaccineCureVac SE·Filed 2023·Application pending·0 cites
- 3988US2026071224A1Artificial nucleic acid molecules for improved protein expressionCureVac SE·Filed 2025·Application pending·0 cites
- 4087US12460204B2Artificial nucleic acid molecules for improved protein or peptide expressionCureVac SE·Filed 2020·Granted Nov 4, 2025·1 cites·33 claims
- 4187US12390523B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Aug 19, 2025·0 cites·119 claims
- 4287US11542490B2RNAs for wound healingCureVac SE·Filed 2017·Granted Jan 3, 2023·8 cites·20 claims
- 4387US2025152745A1Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2024·Application pending·0 cites
- 4487US2025114307A1Dry powder composition comprising long-chain rnaCureVac SE·Filed 2024·Application pending·0 cites
- 4586US12527856B2Artificial RNA molecules encoding a norovirus antigen and uses thereofCureVac SE·Filed 2024·Granted Jan 20, 2026·0 cites·86 claims
- 4686US12109275B2Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded proteinCureVac SE·Filed 2020·Granted Oct 8, 2024·1 cites·19 claims
- 4786US11964011B2Coronavirus vaccineCureVac SE·Filed 2023·Granted Apr 23, 2024·0 cites·39 claims
- 4886US11723967B2Zika virus vaccineCureVac SE·Filed 2017·Granted Aug 15, 2023·7 cites·15 claims
- 4986US2025302932A1Combination of vaccination and ox40 agonistsCureVac SE·Filed 2024·Application pending·0 cites
- 5086US2026090989A1LIPID NANOPARTICLE mRNA VACCINESCureVac SE·Filed 2025·Application pending·0 cites
Showing the top 50 of 118 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →